Small Steps Towards Improving Activity and Sleep Habits to Decrease the Risk of Dementia
Launched by UNIVERSITY OF SOUTH AUSTRALIA · Feb 26, 2024
Trial Information
Current as of October 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Small Steps Towards Improving Activity and Sleep Habits to Decrease the Risk of Dementia," is designed to help older adults reduce their risk of dementia by encouraging healthier habits. The study involves participants aged 65 and older who are not currently meeting recommended physical activity guidelines. Those who join will use a special website called 'Small Steps' that helps them track how they spend their time and suggests small changes to improve their physical activity and sleep quality. Participants will be randomly placed in one of two groups: one that receives more support in making these changes (the 'Extended Program') and another that receives less support (the 'Condensed Program').
The program lasts for 36 weeks, divided into three phases of 12 weeks each, where participants will receive guidance on how to reduce sitting time, increase exercise, and improve sleep. Throughout the trial, participants will take part in health assessments and complete surveys about their sleep and motivation. To be eligible, participants must be ambulatory, fluent in English, and have access to technology like a smartphone or computer. However, those with a current diagnosis of dementia, severe cognitive impairment, or certain disabilities will not qualify for the study. This trial aims to empower older adults to make small but impactful lifestyle changes that may help protect their brain health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged 65 years or older
- • Ambulatory and community dwelling
- • Fluent in the English Language (required for cognitive assessments)
- • Resident of Onkaparinga Council
- • Access and competency in using technology (i.e., phone, tablet, computer)
- • Not meeting the Australian physical activity guidelines - 150 minutes per week of moderate intensity physical activity (self-report)
- • Deemed safe to participate in physical activity (ESSA APSS stage 1) or clearance from health professional
- Exclusion Criteria:
- • Scores below the mild cognitive impairment (MCI) cut-off (\<13/22) on the Montreal Cognitive Assessment-Blind (MoCA-B) or a current diagnosis of dementia
- • Self-reported meeting the Australian physical activity guidelines
- • Major neurological or psychiatric diagnosis
- • Known intellectual disability
- • Major physical disability
- • Lack of English fluency
- • Involved in another intervention trial involving physical activity, brain training, and/or diet
- • Have vision problems which may prevent them from reading a computer and/or phone screen
About University Of South Australia
The University of South Australia (UniSA) is a leading research institution dedicated to advancing health and well-being through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, UniSA leverages its extensive expertise in health sciences, engineering, and technology to conduct rigorous research that addresses pressing healthcare challenges. Committed to translating research findings into practical applications, the university actively engages with industry partners and the community to enhance patient outcomes and contribute to evidence-based practice. Through its state-of-the-art facilities and a team of experienced researchers, UniSA plays a pivotal role in shaping the future of healthcare through high-quality clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Adelaide, South Australia, Australia
Patients applied
Trial Officials
Ashleigh Smith, PhD
Principal Investigator
University of South Australia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported